Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11 MG/KG cnto 136----1件: 49 💬
210 MG/KG cnto 136----1件: 49 💬
3118-42-3----2件: 46, 49 💬
42-deoxy-2 [F-18] fluoro-2-D-glucose----1件: 49 💬
54 MG/KG cnto 136----1件: 49 💬
681MG aspirin----1件: 49 💬
7A-319----1件: 49 💬
8A-623----1件: 49 💬
9AB-101----4件: 35, 44, 46, 49 💬
10Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
11Abatacept also known AS orencia also known AS CTLA4-IG1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 49 💬
12ABBV-105----2件: 46, 49 💬
13ABBV-319----1件: 49 💬
14Abetimus sodium1件: Abetimus1件: Abetimus sodium 💬 --1件: 49 💬
15ABR-215757----2件: 49, 51 💬
16ABT-199----1件: 49 💬
17ABT-494----7件: 41, 46, 49, 96, 97, 107, 271 💬
18AC0058TA----1件: 49 💬
19Acazicolcept1件: Acazicolcept1件: Acazicolcept 💬 2件: CD28,
ICOS 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬1件: 49 💬
20Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
21Acetaminophen/paracetamol1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 35, 49 💬
22Acetate1件: Acetate---14件: 11, 46, 49, 51, 70, 71, 73, 76, 89, 97, 158, 235, 265, 299 💬
23Acido micofenolico1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 49, 51 💬
24ACM----1件: 49 💬
25ACT-334441----1件: 49 💬
26Acthar1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 2, 13, 46, 49, 50, 222 💬
27Acthar GEL1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 13, 46, 49, 84, 222 💬
28AD26.COV2.S----7件: 13, 35, 46, 49, 50, 51, 107 💬
29ADI-001----2件: 49, 51 💬
30Administration OF methylprednisolone + prednisone + mycophenolate mofetil----1件: 49 💬
31Administration OF methylprednisolone, paracetamol and dexchlorpheniramine----1件: 49 💬
32Aerobic exercises----1件: 49 💬
33Afimetoran1件: Afimetoran1件: Afimetoran 💬 --1件: 49 💬
34AGS-009----1件: 49 💬
35Aidsvax® B/E----1件: 49 💬
36AKBM-3031----1件: 49 💬
37Aldesleuchina----1件: 49 💬
38Aldesleukin1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬5件: 2, 49, 65, 96, 97 💬
39Alitretinoin1件: Alitretinoin1件: Alitretinoin 💬 5件: RARA,
RARB,
RXRA,
RXRB,
RXRG 💬 		20件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 49 💬
40Allogeneic bone marrow transplant----1件: 49 💬
41Allogeneic mesenchymal stromal cells derived from THE umbilical cord----1件: 49 💬
42Allogeneic stem cell transplantation----5件: 19, 20, 49, 62, 84 💬
43Alpha-tocopherol1件: Vitamin E1件: Vitamin E 💬 --2件: 49, 206 💬
44ALPN-101----1件: 49 💬
45ALX-0061----2件: 46, 49 💬
46ALX-0061 150 MG/ML----1件: 49 💬
47AMG 557----1件: 49 💬
48AMG 570----1件: 49 💬
49AMG 592----3件: 46, 49, 97 💬
50AMG 623----1件: 49 💬
51AMG 811----1件: 49 💬
52AMG592----2件: 46, 49 💬
53AMG811----1件: 49 💬
54Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬19件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
55Angiotensin converting enzyme test1件: Angiotensin II3件: Angiotensin II ,
Angiotensin II ,
Angiotensin II acetate 💬 		2件: AGTR1,
AGTR2 💬 		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 49 💬
56Anifrolumab1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬5件: 46, 49, 50, 51, 53 💬
57Anifrolumab 1000 MG1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49 💬
58Anifrolumab 300 MG1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49 💬
59Anti LP40 antibody, subclass IGG4----1件: 49 💬
60Anti LP40 anticuerpo, subclase IGG4----1件: 49 💬
61Anti phospholipid marker----1件: 49 💬
62ANTI-bcma/CD70-CAR-T cells----1件: 49 💬
63ANTI-blood dendritic cell antigen 2----1件: 49 💬
64ANTI-CD19 CAR T cell therapy----4件: 49, 50, 51, 53 💬
65ANTI-CD19 CAR-NK cells----3件: 49, 51, 53 💬
66ANTI-CD19-CAR-T cells----3件: 49, 51, 53 💬
67ANTI-CD19-CD3E-CAR-T cells----3件: 49, 51, 53 💬
68ANTI-CD20 B cell depletion with truxima----1件: 49 💬
69ANTI-CD28DAB----3件: 49, 53, 160 💬
70ANTI-macrophage migration inhibitory factor (ANTI-MIF) antibody----1件: 49 💬
71ANTI-pandemic H1n1 influenza vaccine----6件: 46, 49, 50, 51, 53, 107 💬
72ANTI-thymocyte globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
73APG-2575----1件: 49 💬
74Aspirin1件: Acetylsalicylic acid1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
75Aspirin and meloxicam1件: Acetylsalicylic acid1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
76Assigned interventions CD19/bcma CAR T-cells----3件: 49, 51, 53 💬
77ATA3219----1件: 49 💬
78Atacicept1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬5件: 13, 46, 49, 66, 222 💬
79Atacicept 150 MG1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
80Atacicept 75 MG1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
81Athena CAR-T----1件: 49 💬
82Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬17件: 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
83Autologous EBV specific CTL infusion----1件: 49 💬
84Autologous hematopoietic stem cell transplantation----7件: 11, 13, 14, 28, 49, 51, 84 💬
85Autologous peripheral blood stem cell transplantation----8件: 28, 40, 41, 42, 45, 46, 49, 283 💬
86Aviptadil1件: Aviptadil1件: Aviptadil 💬 --4件: 49, 51, 84, 86 💬
87Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--22件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
88AZD0120----1件: 49 💬
89AZD5492----1件: 49 💬
90Balanced diet----1件: 49 💬
91Baricinitib----1件: 49 💬
92Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
93BCMA-CD19 CAR-T therapy----5件: 49, 51, 53, 56, 64 💬
94Bcma/CD19 CAR-T cells----2件: 49, 53 💬
95Belimumab1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
96Belimumab 1 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
97Belimumab 10 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 43, 46, 49 💬
98Belimumab 10 MG/KG plus standard therapy1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
99Belimumab 100 MG SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
100Belimumab 10MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
101Belimumab 200 MG SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
102Belimumab 200 MG/ML1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
103Belimumab 4 MG/KG1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
104Belimumab autoinjector1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
105Belimumab FOR IV1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
106Belimumab FOR SC1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
107Belimumab IN SLE patients / rituximab IN RA patients1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
108Belimumab injection1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
109Belimumab or benlysta1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
110Belimumab plus early vaccination1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
111Belimumab plus late vaccination1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
112Benazepril pill1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 49 💬
113Bendamustine1件: Bendamustine3件: Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--3件: 28, 49, 51 💬
114Benlysta1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 49, 66, 222 💬
115Benlysta 400 MG powder FOR concentrate FOR solution FOR infusion1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 43, 49 💬
116Benlysta 400 MG powder FOR concentrate FOR solution FOR infusions1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
117BI 705564----1件: 49 💬
118BIIB059----1件: 49 💬
119Biospecimen collection----18件: 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
120Blinatumomab1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 11, 46, 49 💬
121Blinatumomab 9UG1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49 💬
122Blisibimod1件: Blisibimod1件: Blisibimod 💬 --5件: 43, 44, 49, 63, 66 💬
123Blood drawing only group C----1件: 49 💬
124Blood sample----28件: 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
125Blood sampling----9件: 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
126BMS-188667----10件: 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
127BMS-9316991件: Lulizumab pegol---3件: 49, 53, 160 💬
128BMS-986165----3件: 49, 96, 97 💬
129BMS-986165 capsule----1件: 49 💬
130BMS-986165 tablet----1件: 49 💬
131BMS-9861951件: Branebrutinib1件: Branebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 46, 49, 53 💬
132BMS-986256-06, TLR7/8 antagonist1件: Afimetoran1件: Afimetoran 💬 --1件: 49 💬
133BMS-986326----1件: 49 💬
134BMS986195----3件: 46, 49, 53 💬
135BNT162b2, bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
136Bone densitometry----2件: 49, 162 💬
137Bortezomib2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
138BOS161721----1件: 49 💬
139BR-DIM----1件: 49 💬
140Branebrutinib1件: Branebrutinib1件: Branebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 46, 49, 53 💬
141Brentuximab vedotin1件: Brentuximab vedotin1件: Brentuximab vedotin 💬 10件: TNFRSF8,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 49, 51 💬
142Brepocitinib----2件: 49, 50 💬
143BRL-301----3件: 49, 51, 53 💬
144BT063----1件: 49 💬
145Budoprutug1件: Budoprutug---1件: 49 💬
146Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
147CABA-201----3件: 11, 49, 51 💬
148Calciferol1件: Vitamin D---1件: 49 💬
149Calcitriol1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬8件: 18, 37, 46, 49, 66, 96, 235, 326 💬
150Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--12件: 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
151Calcium and VIT D1件: Calcium---1件: 49 💬
152Campath1件: Alemtuzumab1件: Alemtuzumab 💬 --3件: 49, 51, 60 💬
153CAR-T cell----1件: 49 💬
154CAR-T therapy----2件: 49, 51 💬
155CART19----1件: 49 💬
156CB-0101件: CB-010---1件: 49 💬
157CBC----1件: 49 💬
158CC-220----1件: 49 💬
159CC-97540----4件: 11, 13, 49, 51 💬
160CC312----5件: 46, 49, 51, 61, 63 💬
161CCX168----6件: 43, 44, 49, 66, 109, 222 💬
162CD19 CAR-T cell infusion----1件: 49 💬
163CD19 CAR-T cells----1件: 49 💬
164CD19 universal CAR-?D T cells----1件: 49 💬
165CD19 universal CAR-T cells----1件: 49 💬
166CD19- bcma CAR-T cells----4件: 43, 49, 51, 53 💬
167CD19-bcma CAR-T cells infusion----3件: 49, 51, 53 💬
168CD19-CAR-DNT cells----2件: 49, 51 💬
169CD19/bcma CAR-T cell therapy----1件: 49 💬
170CD20/BCMA-directed CAR-T cells----3件: 11, 13, 49 💬
171CD34+ peripheral blood stem cell reinfusion----1件: 49 💬
172CDP3194----1件: 49 💬
173CDP7657----1件: 49 💬
174Cellcept1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬5件: 11, 13, 42, 43, 49 💬
175Cenerimod1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
176Cenerimod 0.5 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
177Cenerimod 1 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
178Cenerimod 2 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
179Cenerimod 4 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
180CEP-33457----1件: 49 💬
181Certolizumab pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬7件: 37, 46, 49, 96, 107, 226, 271 💬
182Cervarix suspensie voor injectie----3件: 49, 50, 107 💬
183CFZ533----4件: 11, 46, 49, 53 💬
184Cholecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
185Cholecalciferol and C. xanthorrhiza1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
186Ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 49, 51 💬
187Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬12件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
188Ciclosporina1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 49, 60, 97 💬
189Cimzia1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬6件: 46, 49, 96, 97, 107, 271 💬
190Clinical laboratory evaluations - biochemistry----1件: 49 💬
191Clinical laboratory evaluations - hematology----1件: 49 💬
192Clinical laboratory evaluations - serology----1件: 49 💬
193CLN-978----1件: 49 💬
194Clopidogrel1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬4件: 40, 49, 51, 86 💬
195CM313 injection----3件: 35, 49, 63 💬
196CNCT19 cell injection----1件: 49 💬
197CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
198CNTY-101----2件: 49, 51 💬
199Coaching sessions----1件: 49 💬
200Collection OF samples----4件: 49, 65, 95, 107 💬
201Computed tomography----12件: 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
202Concomitant medication----1件: 49 💬
203Conjugated equine estrogens 0.625 MG/D + MPA 5 MG/D/10D1件: Conjugated estrogens1件: Estrogens, conjugated 💬 --1件: 49 💬
204Continuation OF azathioprine----1件: 49 💬
205Conventional pharmacotherapy----1件: 49 💬
206Conventional therapy----5件: 6, 49, 67, 97, 222 💬
207Corn starch1件: Starch, corn1件: Corn starch 💬 --2件: 49, 97 💬
208Corticosteroids----12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
209Covid-19 vaccine----5件: 13, 46, 49, 51, 97 💬
210Creatine1件: Creatine---10件: 1, 2, 6, 8, 13, 46, 49, 50, 201, 337 💬
211Crestor1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬3件: 49, 79, 299 💬
212CSA----5件: 19, 49, 60, 63, 222 💬
213CTLA4IG----4件: 46, 49, 96, 271 💬
214CUG252----1件: 49 💬
215Cumulative corticosteroid exposure----1件: 49 💬
216Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
217Cyclophosphamide LD1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 49 💬
218Cyclophosphamide-prednisone-azathioprine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 49 💬
219Cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
220Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
221Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 19, 20, 36, 49, 50, 58, 60, 107, 228, 234, 283 💬
222Cymbalta1件: Duloxetine2件: Duloxetine hydrochloride ,
Duloxetine 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 49 💬
223Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--7件: 11, 13, 14, 25, 34, 49, 60 💬
224Cytokines and chemokine profiling----1件: 49 💬
225Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --10件: 6, 28, 49, 66, 67, 86, 88, 215, 218, 222 💬
226Dapirolizumab pegol1件: Dapirolizumab pegol---2件: 13, 49 💬
227Daratumumab1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬7件: 13, 28, 46, 48, 49, 60, 63 💬
228Daratumumab injection1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬4件: 16, 28, 49, 63 💬
229Darzalex1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63 💬
230Daxdilimab1件: Daxdilimab1件: Daxdilimab 💬 1件: LILR 💬 2件: B cell receptor signaling pathway, Osteoclast differentiation 💬2件: 49, 50 💬
231DB-2304----1件: 49 💬
232Dehydroepiandrosterone1件: Prasterone1件: Prasterone 💬 3件: AR,
ESR1,
ESR2 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬4件: 49, 53, 83, 96 💬
233Deltacortene*20CPR 5MG----3件: 49, 97, 113 💬
234Depletion OF CD3/CD19 IN AN autologous stem cell transplant----2件: 49, 51 💬
235Descartes-08----2件: 11, 49 💬
236Deucravacitinib1件: Deucravacitinib1件: Deucravacitinib 💬 1件: TYK2 💬 17件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
237Dhea1件: Prasterone1件: Prasterone 💬 3件: AR,
ESR1,
ESR2 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 49, 96 💬
238Dihydroartemisinin tablet1件: Artenimol1件: Artenimol 💬 --1件: 49 💬
239Dimethylfumarat1件: Dimethyl fumarate1件: Dimethyl fumarate 💬 1件: KLHL19 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 49 💬
240Diphenhydramine1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬10件: 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
241Diphenhydramine hydrochloride1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 11, 49 💬
242Docosahexaenoic acid1件: Doconexent---6件: 6, 49, 90, 94, 240, 299 💬
243Doppler ultrasound----1件: 49 💬
244Drug free----1件: 49 💬
245Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom----2件: 46, 49 💬
246DS-7011A----1件: 49 💬
247DZP----1件: 49 💬
248E6742----1件: 49 💬
249Edratide1件: Edratide1件: Edratide 💬 --1件: 49 💬
250Edratide acetate1件: Edratide1件: Edratide 💬 --1件: 49 💬
251Efavaleukin alfa1件: Efavaleukin alfa1件: Efavaleukin alfa 💬 --2件: 49, 97 💬
252Eicosapentaenoic acid1件: Icosapent1件: Icosapent 💬 --6件: 49, 96, 97, 296, 297, 338 💬
253Electrocardiogram----2件: 49, 58 💬
254Elsubrutinib1件: Elsubrutinib1件: Elsubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
255Emapalumab1件: Emapalumab1件: Emapalumab 💬 1件: IFNG 💬 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬4件: 49, 54, 60, 107 💬
256Endoxan----6件: 13, 28, 49, 51, 85, 162 💬
257Engineering OF chimeric antigen receptors targeting CD19 IN allogeneic T cells----1件: 49 💬
258Enpatoran1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
259Enpatoran 25MG1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
260Enpatoran 50MG1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
261Enpatoran high dose1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
262Enpatoran LOW dose1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
263Enpatoran medium dose1件: Enpatoran1件: Enpatoran 💬 2件: TLR7,
TLR8 💬 		5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬1件: 49 💬
264Enteric-coated mycophenolate sodium----1件: 49 💬
265EPA and DHA supplementation----2件: 48, 49 💬
266Epatuzumab----1件: 49 💬
267Epratuzumab1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
268Epratuzumab 100 MG1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
269Epratuzumab 1200 MG1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
270Epratuzumab 400 MG1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
271Epratuzumab 600 MG1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
272Epratuzumab IV1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
273Epratuzumab SC1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
274Equecabtagene autoleucel injection1件: Equecabtagene autoleucel---1件: 49 💬
275ERL080A----1件: 49 💬
276ESK-001----1件: 49 💬
277Ethinyl estradiol1件: Ethinylestradiol1件: Ethinyl estradiol 💬 1件: ESR1 💬 9件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 46, 49, 299 💬
278Ethylhydrogenfumarat, calciumsalz----1件: 49 💬
279Ethylhydrogenfumarat, magnesiumsalz----1件: 49 💬
280Ethylhydrogenfumarat, zinksalz----1件: 49 💬
281Evobrutinib1件: Evobrutinib1件: Evobrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 13, 46, 49 💬
282Extended release dipyridamole 200MG/aspirin 25MG----1件: 49 💬
283Ezetimibe+simvastatin drug combination1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬1件: 49 💬
284FAN beam CT scan----1件: 49 💬
285Fecal microbiota1件: Fecal microbiota---5件: 13, 49, 93, 96, 97 💬
286Fibrinogen TO albumin ratio and C-reactive TO albumin ratio1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 49 💬
287Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬29件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
288Fish OIL1件: Fish oil---5件: 13, 46, 49, 96, 299 💬
289Fitbit activity monitor----1件: 49 💬
290Flash glucose monitoring system----1件: 49 💬
291FLOW-mediated dilation OF THE brachial artery----1件: 49 💬
292Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬23件: 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
293Fludarabine phosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
294Fluorine F 18 clofarabine----4件: 40, 46, 49, 96 💬
295Fluzone----1件: 49 💬
296Focetria----3件: 46, 49, 271 💬
297Forigerimod1件: Forigerimod1件: Forigerimod 💬 --1件: 49 💬
298Fostamatinib1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬3件: 46, 49, 63 💬
299FT819----2件: 49, 51 💬
300Full history , clinical examination, assesment OF disease activity ,laboratory investigations ( CBC , ESR, CRP serum creatinine and blood urea, random plas----2件: 46, 49 💬
301Fumaderm® initial----1件: 49 💬
302G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬18件: 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
303Gardasil----1件: 49 💬
304Gazyvaro1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 49, 222 💬
305GB261----1件: 49 💬
306GC+HCQ----1件: 49 💬
307GC012F injection----2件: 11, 49 💬
308GDC-0853----3件: 13, 46, 49 💬
309GDC-0853 RO7010939----3件: 13, 46, 49 💬
310Genotype detection----1件: 49 💬
311GL701----1件: 49 💬
312GLPG3667----2件: 49, 50 💬
313GLPG3970 FILM-coated tablet----1件: 49 💬
314Glucocorticoid----6件: 46, 49, 66, 113, 220, 228 💬
315GNC-038----2件: 46, 49 💬
316Group A SLE prospective study----1件: 49 💬
317Group B SLE ONE blood donation----1件: 49 💬
318GSK1550188----4件: 11, 49, 66, 222 💬
319GSK1550188 1MG/KG or 10MG/KG----1件: 49 💬
320GSK1550188 IV----1件: 49 💬
321GSK1550188 SC----1件: 49 💬
322GSK2586184----1件: 49 💬
323GSK2586184 100 MG----1件: 49 💬
324GSK2586184 200 MG----1件: 49 💬
325GSK2586184 400 MG----1件: 49 💬
326GSK2586184 50 MG----1件: 49 💬
327GSK2586184 800MG single and repeat dose----1件: 49 💬
328GSK2586184 NEW formulation----1件: 49 💬
329GSK2586184 single dose taken with food----1件: 49 💬
330GSK2586184 single dose taken without food----1件: 49 💬
331GSK2586184 standard formulation----1件: 49 💬
332GSK4347859----1件: 49 💬
333GSK4527363----1件: 49 💬
334Gusacitinib1件: Gusacitinib1件: Gusacitinib 💬 4件: JAK1,
JAK2,
JAK3,
SYK 💬 		48件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neutrophil extracellular trap formation, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
335H.P. acthar GEL----5件: 46, 49, 50, 84, 222 💬
336HA 1A anticorpo monoclonale umano classe IGM----2件: 6, 49 💬
337HB-admscs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---7件: 2, 4, 6, 13, 14, 46, 49 💬
338HC022----1件: 49 💬
339HCQ----2件: 46, 49 💬
340Heart health educational program----1件: 49 💬
341Hematopoietic cell transplantation----2件: 49, 60 💬
342Hematopoietic stem cell transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
343Herpes zoster subunit (HZ/SU) vaccine----1件: 49 💬
344Herpes zoster vaccine----9件: 46, 49, 50, 51, 53, 56, 96, 107, 271 💬
345HGS1006----1件: 49 💬
346HGS1006, lymphostat-B, monoclonal ANTI-blys, LSB, benlysta1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
347High dietary sodium----1件: 49 💬
348High dose GR1603 IN phase?B----1件: 49 💬
349HLL2----1件: 49 💬
350HLL2,IMMU-103----1件: 49 💬
351HN2301 injection----2件: 11, 49 💬
352HPV prophylactic vaccine gardasil----1件: 49 💬
353HRIL-2 active----3件: 46, 49, 53 💬
354Human umbilical cord derived MSC transplantation FOR SLE----1件: 49 💬
355Humanised IGG1 monoclonal antibody against blood dendritic cell antigen 2----1件: 49 💬
356Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--26件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
357Hydroxychloroquine or chloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 49 💬
358Hydroxychloroquine reduced1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 49 💬
359HZN-7734, VIB7734, MEDI7734----1件: 49 💬
360Ianalumab1件: Ianalumab1件: Ianalumab 💬 1件: TNFRSF13C 💬 5件: Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
361Ibandronate+alfacalcidol+calcium1件: Ibandronate2件: Ibandronate sodium ,
Ibandronic acid 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 49 💬
362ICP-022----3件: 13, 46, 49 💬
363IFN-A 2B kinoid drug substance----1件: 49 💬
364IFN-A2B kinoid----1件: 49 💬
365IFN-K----2件: 49, 50 💬
366IFN-kinoid----2件: 49, 50 💬
367IFN-kinoid drug substance----2件: 49, 50 💬
368IFNA-kinoid----2件: 49, 50 💬
369Iguratimod1件: Iguratimod1件: Iguratimod 💬 1件: NFKB1 💬 75件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬6件: 46, 49, 51, 53, 271, 300 💬
370IL-21件: Human interleukin-2---5件: 2, 46, 49, 51, 53 💬
371IL-61件: Human interleukin-6---3件: 46, 49, 86 💬
372IL-6R nanobody----1件: 49 💬
373ILT-1011件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 49 💬
374IM19 CAR-T cells----1件: 49 💬
375IMC-002 + SOC----1件: 49 💬
376IMMU-103----1件: 49 💬
377Immunoglobulin G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
378Immunoglobulin G1, ANTI-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer----1件: 49 💬
379Immunologic technique----3件: 49, 65, 285 💬
380IMPT-514----1件: 49 💬
381IMPT-514 cart cell injection----1件: 49 💬
382Imvotamab1件: Imvotamab1件: Imvotamab 💬 2件: CD3E,
MS4A1 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 46, 49 💬
383Inaticabtagene autoleucel injection1件: Inaticabtagene Autoleucel---1件: 49 💬
384Individualized dose OF rituximab----1件: 49 💬
385Inebilizumab1件: Inebilizumab1件: Inebilizumab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬6件: 11, 13, 46, 49, 51, 300 💬
386Infliximab1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 164, 269, 270, 271 💬
387Influenz virus surface antigens----1件: 49 💬
388Influvac----3件: 46, 49, 50 💬
389Interleukin 2----11件: 35, 46, 49, 51, 56, 63, 95, 96, 97, 162, 271 💬
390Interleukin 23----1件: 49 💬
391Interleukin-21件: Human interleukin-2---9件: 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
392Intravenous immunoglobulin----8件: 13, 14, 35, 38, 39, 49, 51, 309 💬
393IPP - 201101----1件: 49 💬
394IPP-201101----1件: 49 💬
395IPP-201101, P140----1件: 49 💬
396ISA 51 VG----1件: 49 💬
397Iscalimab1件: Iscalimab1件: Iscalimab 💬 1件: TNFRSF5 💬 17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬2件: 49, 53 💬
398Isoniazid/pyridoxine1件: Isoniazid1件: Isoniazid 💬 --1件: 49 💬
399Itolizumab1件: Itolizumab1件: Itolizumab 💬 1件: CD6 💬 1件: Cell adhesion molecules 💬2件: 49, 50 💬
400JBT-1011件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬4件: 49, 50, 51, 299 💬
401JMKX000189----1件: 49 💬
402JNJ-54767414----2件: 28, 49 💬
403JNJ-55920839----1件: 49 💬
404JNJ-56022473----1件: 49 💬
405JNJ-80202135----4件: 11, 46, 49, 53 💬
406JY231 injection----1件: 49 💬
407Ketogenic diet----9件: 13, 19, 21, 49, 67, 77, 127, 145, 148 💬
408Kineret1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬6件: 41, 49, 65, 106, 266, 299 💬
409KK4277----1件: 49 💬
410KP104----3件: 49, 62, 66 💬
411KPG-818----1件: 49 💬
412KPG-818 high dose----1件: 49 💬
413KPG-818 LOW dose----1件: 49 💬
414KPG-818 MID dose----1件: 49 💬
415KZR-616----3件: 49, 50, 61 💬
416L04aa26----1件: 49 💬
417LA294----1件: 49 💬
418Laboratory biomarker analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
419Lacteol forte capsules1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 49 💬
420Laquinimod1件: Laquinimod1件: Laquinimod sodium 💬 --4件: 8, 13, 49, 96 💬
421LCAR-AIO T cells----3件: 11, 13, 49 💬
422Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬13件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 224, 270, 271, 300 💬
423Lenalidomide1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
424Leukapheresis----5件: 49, 51, 96, 284, 285 💬
425Levothyroxine1件: Levothyroxine3件: Levothyroxine sodium ,
Levothyroxine ,
Levothyroxine sodium 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬3件: 49, 78, 80 💬
426Lisinopril pills1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 49 💬
427Litifilimab1件: Litifilimab1件: Litifilimab 💬 --1件: 49 💬
428LJP 394----1件: 49 💬
429LJP394----1件: 49 💬
430LMY-920----1件: 49 💬
431LOW dietary sodium----1件: 49 💬
432LOW dose GR1603 IN phase ?B----1件: 49 💬
433Lulizumab pegol1件: Lulizumab pegol---1件: 49 💬
434Lupus impact tracker questionnaire----1件: 49 💬
435Lupuzor----1件: 49 💬
436LY2127399----3件: 13, 46, 49 💬
437LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
438LY3361237----2件: 49, 53 💬
439LY3471851----2件: 49, 97 💬
440Lymphodepleting chemotherapy----2件: 49, 51 💬
441Lymphostat-B----1件: 49 💬
442Lymphostat-B (LSB), monoclonal ANTI-blys, LSB----1件: 49 💬
443Lymphostat-B TM----1件: 49 💬
444M281----5件: 11, 46, 49, 53, 61 💬
445M2951----3件: 13, 46, 49 💬
446M5049----1件: 49 💬
447M5049 high dose----2件: 49, 50 💬
448M5049 LOW dose----1件: 49 💬
449M5049 medium dose----1件: 49 💬
450M5049 very high dose----1件: 49 💬
451MB-CART19.1----1件: 49 💬
452MC-1-501件: MC-1---1件: 49 💬
453Medi 545----1件: 49 💬
454MEDI-545----2件: 49, 50 💬
455MEDI-545 600----1件: 49 💬
456MEDI-546----2件: 49, 51 💬
457MEDI-570 0.03 MG----1件: 49 💬
458MEDI-570 0.1 MG----1件: 49 💬
459MEDI-570 0.3 MG----1件: 49 💬
460MEDI-570 1 MG----1件: 49 💬
461Medroxyprogesterone----1件: 49 💬
462Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬16件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
463Memantine1件: Memantine2件: Memantine hydrochloride ,
Memantine 💬 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206 💬
464Mesenchymal stem cells----17件: 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 97, 107, 222, 271, 274, 298, 299 💬
465Mesna----11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
466Metabolically armed CD19 CAR-T cells----1件: 49 💬
467Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
468Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
469Methotrexate and folic acid1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 49 💬
470Methyl prednisolone----2件: 49, 96 💬
471Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
472Methylprednisolone sodium succinate1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 13, 46, 49, 50, 51, 211 💬
473MHS552----1件: 49 💬
474Micofenolato mofetile----2件: 49, 53 💬
475Micofenolico acido1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 49 💬
476MIL62----3件: 13, 49, 222 💬
477Milatuzumab1件: Milatuzumab1件: Milatuzumab 💬 1件: CD74 💬 3件: Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis 💬1件: 49 💬
478Milnacipran1件: Milnacipran2件: Milnacipran hydrochloride ,
Milnacipran 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 46, 49 💬
479Mizoribine1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 46, 49, 51, 53, 66, 94, 222, 224 💬
480MK-6194----2件: 49, 97 💬
481MMF----15件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
482MMF discontinuation----7件: 46, 49, 50, 51, 53, 56, 107 💬
483MMF maintain----7件: 46, 49, 50, 51, 53, 56, 107 💬
484Modafinil1件: Modafinil1件: Modafinil 💬 --4件: 6, 13, 49, 93 💬
485Moderna MRNA-1273, bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
486Monovalent [B.1.351] COV2 pres DTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107 💬
487Mosunetuzumab1件: Mosunetuzumab1件: Mosunetuzumab 💬 2件: CD3E,
MS4A1 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49 💬
488Moxifloxacin1件: Moxifloxacin3件: Moxifloxacin hydrochloride ,
Moxifloxacin ,
Moxifloxacin hydrochloride monohydrate 💬 		--7件: 2, 6, 46, 49, 85, 240, 299 💬
489MPA----8件: 13, 35, 46, 49, 50, 51, 60, 107 💬
490MRA 003 US----1件: 49 💬
491MRI, venipuncture----1件: 49 💬
492Mrna COVD19 vaccine----4件: 49, 53, 97, 271 💬
493MRNA-1273----7件: 13, 35, 46, 49, 50, 51, 107 💬
494MSC treatment----1件: 49 💬
495MSC2364447C----2件: 13, 49 💬
496MT-1303 high dose----1件: 49 💬
497MT-1303 LOW dose----1件: 49 💬
498MTX----14件: 13, 35, 40, 46, 49, 50, 51, 54, 55, 60, 84, 96, 107, 162 💬
499MTX discontinuation----7件: 46, 49, 50, 51, 53, 56, 107 💬
500MTX maintain----7件: 46, 49, 50, 51, 53, 56, 107 💬
501Multivitamin----1件: 49 💬
502Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
503Mycophenolate mofetil 500MG2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬3件: 49, 51, 61 💬
504Mycophenolate motetil1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 49 💬
505Mycophenolic acid1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 11, 43, 49, 51, 60, 66, 96, 222 💬
506Myfortic1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬4件: 49, 66, 222, 228 💬
507Myfortic*50CPR RIV 360MG1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 49 💬
508N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-YL)cyclopropanecarboxamide----1件: 49 💬
509N-acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --14件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
510Nelfinavir1件: Nelfinavir2件: Nelfinavir mesylate ,
Nelfinavir 💬 		--3件: 49, 265, 331 💬
511NI-0501----3件: 49, 54, 107 💬
512Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --5件: 6, 18, 49, 107, 162 💬
513Nicotinamide riboside3件: Nicotinamide,
Nicotinamide riboside,
Zinc		1件: Niacinamide 💬 --13件: 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
514Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
515Nivolumab1件: Nivolumab1件: Nivolumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
516NK 010 or NK042----1件: 49 💬
517NK cells1件: Natural Killer Cell---3件: 26, 49, 63 💬
518NKX019----2件: 49, 51 💬
519NNC 0151-0000-0000----2件: 46, 49 💬
520NNC0114-00061件: NNC0114-0006---3件: 46, 49, 96 💬
521NON applicabile----3件: 49, 51, 256 💬
522Norethindrone1件: Norethisterone2件: Norethindrone ,
Norethindrone acetate 💬 		1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299 💬
523Normal saline----20件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
524NOX-E36----1件: 49 💬
525OBE-CEL1件: Obecabtagene autoleucel1件: Obecabtagene autoleucel 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 49 💬
526Obecabtagene autoleucel1件: Obecabtagene autoleucel1件: Obecabtagene autoleucel 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 49 💬
527Obexelimab1件: Obexelimab1件: Obexelimab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬4件: 13, 49, 61, 300 💬
528Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬5件: 43, 44, 49, 63, 222 💬
529Obinutuzumab administration1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 49 💬
530Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 46, 49 💬
531OL-108----2件: 49, 51 💬
532Olive OIL2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬 --3件: 34, 49, 53 💬
533Olumiant1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬9件: 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
534Olumiant - EU/1/16/1170/001-0081件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
535Olumiant - EU/1/16/1170/009-0161件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
536Omacor----1件: 49 💬
537Omega-31件: Omega-3 fatty acids---3件: 46, 49, 96 💬
538Oral prednisolone----3件: 49, 96, 145 💬
539Oral prednisone 5MG----1件: 49 💬
540Orelabrutinib1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬4件: 13, 49, 61, 63 💬
541Orencia1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬15件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
542Orencia 125 MG solution FOR injection IN PRE-filled syringe1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬3件: 46, 49, 53 💬
543Ortho-novum 777----1件: 49 💬
544Oxygen1件: Oxygen1件: Oxygen 💬 --13件: 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
545Ozone1件: Ozone---4件: 49, 51, 70, 226 💬
546P 140----1件: 49 💬
547P-CD19cd20-ALLO1 cells----1件: 49 💬
548Paquinimod1件: Paquinimod---2件: 49, 51 💬
549PF-04236921----2件: 49, 96 💬
550PF-06700841 15 MG1件: PF-06700841---1件: 49 💬
551PF-06700841 25MG1件: PF-06700841---1件: 49 💬
552PF-06700841 30 MG1件: PF-06700841---1件: 49 💬
553PF-06700841 45 MG1件: PF-06700841---1件: 49 💬
554PF-06700841 5MG1件: PF-06700841---1件: 49 💬
555PF-06700841-151件: PF-06700841---3件: 49, 96, 97 💬
556PF-06835375----3件: 46, 49, 63 💬
557Pharmacokinetic analysis----1件: 49 💬
558Phosphate-buffered saline1件: Phosphate ion---1件: 49 💬
559Physical examination----2件: 49, 172 💬
560Physical exercise program----1件: 49 💬
561Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
562PIT565----1件: 49 💬
563Pitavastatin1件: Pitavastatin2件: Pitavastatin calcium ,
Pitavastatin magnesium 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 49 💬
564Plaquenil1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--5件: 46, 49, 53, 84, 96 💬
565Plasmapheresis----4件: 11, 49, 113, 222 💬
566Pneumovax----4件: 46, 49, 96, 97 💬
567Polymorphism analysis----2件: 49, 60 💬
568Pooled mesenchymal stem cell----1件: 49 💬
569Positron emission tomography----6件: 26, 28, 40, 46, 49, 96 💬
570Prasterone1件: Prasterone1件: Prasterone 💬 3件: AR,
ESR1,
ESR2 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
571Pravastatin1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬10件: 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬
572PRE-filled syringe----7件: 46, 49, 53, 96, 97, 107, 271 💬
573Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
574Prednisolone/prednisone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
575Prednisona1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 49, 222 💬
576Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
577Prednisone acetate2件: Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 35, 46, 49, 63, 162, 222 💬
578Prednisone discontinuation1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
579Pregnancy test----2件: 49, 50 💬
580Premarin and provera----1件: 49 💬
581Progressive resisted exercise training----1件: 49 💬
582Proleukin1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬2件: 2, 49 💬
583PRV-3279----1件: 49 💬
584Questionnaires----7件: 3, 6, 13, 28, 41, 49, 96 💬
585Quinipril----1件: 49 💬
586R-salbutamol sulphate1件: Levosalbutamol1件: Levosalbutamol 💬 1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 49 💬
587R932333----1件: 49 💬
588Rabbit ANTI-thymocyte globulin1件: Rabbit---4件: 49, 65, 285, 326 💬
589Rabbit antithymocyte globulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬3件: 49, 60, 96 💬
590Ramipril1件: Ramipril1件: Ramipril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257 💬
591Rankl/OPG ratio----1件: 49 💬
592Rapamycin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬19件: 2, 15, 34, 35, 46, 49, 51, 53, 60, 61, 63, 67, 86, 96, 158, 193, 256, 279, 283 💬
593Rapcabtagene autoleucel regimen 1----1件: 49 💬
594Rapcabtagene autoleucel regimen 2----1件: 49 💬
595Raptiva1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬3件: 37, 49, 53 💬
596Rayos1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
597RC18 160 MG plus standard therapy----1件: 49 💬
598RC18 240 MG plus standard therapy----1件: 49 💬
599RC18 80 MG plus standard therapy----1件: 49 💬
600RD06-04 cart cell injection----3件: 49, 51, 53 💬
601RD06-04 cells injection----1件: 49 💬
602Recombinant factor FC fusion protein----2件: 46, 49 💬
603Recombinant zoster vaccine----2件: 13, 49 💬
604Reduced intensity allogeneic transplant----2件: 49, 51 💬
605Relma-CEL1件: Relmacabtagene autoleucel---2件: 49, 51 💬
606Remicade1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬8件: 46, 49, 56, 84, 85, 96, 97, 271 💬
607Rest OF ANA profile----1件: 49 💬
608Rhumab 2h71件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
609Rhumab ifnalpha----1件: 49 💬
610Rigerimod----1件: 49 💬
611Rimiducid1件: Rimiducid1件: Rimiducid 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬7件: 19, 49, 60, 65, 284, 285, 326 💬
612Riquent----1件: 49 💬
613Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
614Rivaroxaban1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬5件: 46, 49, 91, 210, 271 💬
615Rixathon1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
616RO 106-1443----1件: 49 💬
617RO 496-4913----2件: 46, 49 💬
618RO 5072759----1件: 49 💬
619RO7010939/F13----1件: 49 💬
620RO7507062----1件: 49 💬
621Rontalizumab1件: Rontalizumab1件: Rontalizumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
622Rosuvastatin1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬9件: 6, 18, 46, 49, 51, 79, 94, 96, 271 💬
623Rosuvastatin calcium1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬4件: 49, 79, 97, 299 💬
624Royal jelly1件: Royal jelly1件: Royal jelly 💬 --1件: 49 💬
625Rozibafusp alfa1件: Rozibafusp Alfa1件: Rozibafusp alfa 💬 2件: ICOSLG,
TNFSF13B 💬 		5件: Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
626RSLV-132----2件: 49, 53 💬
627Saccharum lactis----1件: 49 💬
628Saliva sample----1件: 49 💬
629Saphnelo1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 49, 53 💬
630SAR113244----1件: 49 💬
631SAR441344----3件: 13, 49, 53 💬
632SAR441344 IV----2件: 13, 49 💬
633SAR441344 SC----2件: 13, 49 💬
634SBI-087----2件: 46, 49 💬
635SC belimumab 200 MG----1件: 49 💬
636SC291----2件: 43, 49 💬
637SCRI-CAR19v3----1件: 49 💬
638SCTB35 injection----1件: 49 💬
639Seluang fish OIL (rasbora argyrotaenia) and synbiotic----1件: 49 💬
640Serum creatinine and ALB/create ratio----1件: 49 💬
641SF-36 questionnaire----1件: 49 💬
642SG301 SC injection----1件: 49 💬
643Shingrix----4件: 46, 49, 96, 97 💬
644SHR-2173----1件: 49 💬
645Sifalimumab1件: Sifalimumab1件: Sifalimumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
646Sifalimumab 1,200 MG1件: Sifalimumab1件: Sifalimumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
647Sifalimumab 200 MG1件: Sifalimumab1件: Sifalimumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
648Sifalimumab 600 MG1件: Sifalimumab1件: Sifalimumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
649Simvastatin1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
650Single dose OF UC-mscs----1件: 49 💬
651Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬39件: 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
652SLE activity evaluation----1件: 49 💬
653SLE biomarker profiling----1件: 49 💬
654SLE treatment----1件: 49 💬
655Sledai scores----1件: 49 💬
656SM101----3件: 49, 63, 66 💬
657SM934----1件: 49 💬
658Smartphone application----1件: 49 💬
659SOLU-medrol 1MG/KG----1件: 49 💬
660SOLU-medrol 250 MG----1件: 49 💬
661Soluble FC receptor----1件: 49 💬
662Soluble FC-gamma receptor IIB----1件: 49 💬
663SQ fludarabine----1件: 49 💬
664ST 361件: ST-36---2件: 6, 49 💬
665Standard dose OF HCQ----1件: 49 💬
666Standard dose OF rituximab----1件: 49 💬
667Standard therapy----5件: 49, 51, 58, 97, 195 💬
668Standard treatment according TO THE clinical protocols----3件: 49, 51, 235 💬
669Standard-OF-care treatment----1件: 49 💬
670Stelara1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬6件: 49, 56, 96, 97, 269, 271 💬
671Steroid drug----3件: 11, 46, 49 💬
672Steroid taper----1件: 49 💬
673STK-009----2件: 49, 51 💬
674Stood sample----1件: 49 💬
675Stool sample----3件: 6, 49, 299 💬
676Subcuvia----3件: 14, 49, 65 💬
677Sugar pill----9件: 5, 6, 49, 67, 70, 86, 90, 206, 210 💬
678Sulfasalazine tablets1件: Sulfasalazine1件: Sulfasalazine 💬 --1件: 49 💬
679Sulfate1件: Sulfate ion1件: Sulfuric acid 💬 --6件: 2, 3, 11, 49, 222, 224 💬
680Switch TO myfortic----1件: 49 💬
681Syncar-001----2件: 49, 51 💬
682SYS6020----1件: 49 💬
683T cell injection targeting CD19 chimeric antigen receptor----6件: 46, 49, 51, 53, 93, 300 💬
684T cells transduced with chimeric antigen receptor ANTI-CD19----1件: 49 💬
685TAB08----2件: 46, 49 💬
686Tabalumab AUTO-injector1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
687Tabalumab prefilled syringe1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
688TACI-FC51件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 46, 49 💬
689Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
690TAK-079----3件: 11, 49, 63 💬
691Taking peripheral blood samples----1件: 49 💬
692Telitacicept1件: Telitacicept---11件: 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
693Telitacicept 160MG1件: Telitacicept---2件: 49, 66 💬
694Thalidomide1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
695THE generic name IS warfarin and many producers will BE involved1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49 💬
696Tissue sample----1件: 49 💬
697TJ202 injection----1件: 49 💬
698Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬24件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
699Tocopherol acetate2件: Tocopherol,
alpha-Tocopherol acetate		2件: Tocopherol acetate ,
Tocopherol 💬 		--1件: 49 💬
700Tofacitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
701Tofacitinib citrate1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 46, 49, 97, 107, 271 💬
702Total body irradiation----13件: 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
703TQB3702 tablets----1件: 49 💬
704Trade name xarelto1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 49 💬
705Treatment :abacavir 600 MG/lamivudine 300 MG----1件: 49 💬
706Trimethoprim-sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		4件: Trimethoprim ,
Sulfamethoxazole ,
Trimethoprim sulfate ,
Trimethoprim hydrochloride 💬 		--3件: 49, 61, 299 💬
707Triptorelin pamoate1件: Triptorelin3件: Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 49, 76 💬
708TRU-0151件: TRU-015---3件: 46, 49, 222 💬
709TV-4710----1件: 49 💬
710Ucar T-cell group----3件: 11, 49, 61 💬
711Ultrasonography assessment----1件: 49 💬
712Upadacitinib1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬10件: 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
713Urinalysis----1件: 49 💬
714Urine sample----4件: 49, 51, 61, 84 💬
715Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
716Ustekinumab 90 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬5件: 49, 50, 93, 96, 97 💬
717Ustekinumab IV1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 49, 97 💬
718Ustekinumab SC1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 49, 97 💬
719UTAA91 injection----3件: 46, 49, 51 💬
720Vaccination----1件: 49 💬
721Vaccine----6件: 46, 49, 51, 96, 97, 271 💬
722VAY736----9件: 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
723VAY736 1ML PFS----2件: 46, 49 💬
724VAY736 2 ML PFS----2件: 46, 49 💬
725VAY736 2ML AI----2件: 46, 49 💬
726VIB7734----4件: 49, 50, 51, 53 💬
727VIB7734, MEDI7734----1件: 49 💬
728VIP----3件: 49, 51, 86 💬
729VIS171----2件: 49, 222 💬
730Vitamin D1件: Vitamin D---20件: 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
731Vitamin D 25(OH)D1件: Vitamin D---1件: 49 💬
732Vitamin D21件: Ergocalciferol1件: Ergocalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 49, 299 💬
733Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 6, 13, 20, 46, 49, 51, 53, 65, 96, 97, 299 💬
734Vitamin D3 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
735Vitamin D3 6000 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
736Vitamins: B6, B12, and folate----1件: 49 💬
737Vobarilizumab1件: Vobarilizumab1件: Vobarilizumab 💬 --1件: 49 💬
738Voclosporin1件: Voclosporin1件: Voclosporin 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 49, 222 💬
739Vunakizumab1件: Vunakizumab---2件: 49, 51 💬
740Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬10件: 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
741Warfarin sodium1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49 💬
742Without anticoagulation----1件: 49 💬
743XMAB5871----2件: 49, 300 💬
744YTB323----2件: 11, 49 💬
745YTS109 cell----4件: 46, 49, 51, 53 💬
746YTS109 cell injection----1件: 49 💬
747YU-tone music intervention----1件: 49 💬
748Zamtocabtagene autoleucel1件: Zamtocabtagene autoleucel---2件: 49, 51 💬
749Zishenqing----1件: 49 💬
750ZM001 injection----1件: 49 💬
751Zostavax----2件: 46, 49 💬
752Zostavax vaccine----2件: 46, 49 💬